UnknownN/ALSD

Investigating Lysosomal Storage Diseases in Minority Groups

Sponsored by O & O Alpan LLC

NCT ID
NCT02120235
Target Enrollment
20,000 participants
Start Date
2014-02
Est. Completion
2018-12

About This Study

Although lysosomal storage disorders, such as Fabry disease, Gaucher disease, and Pompe disease, represent serious challenges in the healthcare system, no study has yet investigated the prevalence of these diseases in the US. Frequently, patients show progressive worsening of symptoms for several years before they get diagnosed. Since many of these diseases can be managed therapeutically, it is important to identify and treat patients in order to avoid organ damage. The investigators aim to undertake a screening study that identifies undiagnosed patients with lysosomal storage disorders and determine the prevalence of these diseases with special focus on underrepresented minority groups.

Conditions Studied

Lysosomal Storage DisordersGaucher DiseaseFabry DiseasePompe DiseaseNiemann-Pick Disease

Eligibility

Age:1 Day - 100 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Subject is greater than or equal to 1 day of age and less than or equal to 100 years of age
* Subject is managed by a physician in the Washington, D.C metro area
* Subject is getting blood work as part of standard clinical care and there is at least 60 uL blood remained in a tube after all clinical tests were run

Exclusion Criteria:

* Absolute contraindication for blood drawing
* Subject cannot be traced back by the referring physician upon a positive screening result

Study Locations (1)

O&O Alpan, LLC
Fairfax, Virginia, United States

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Investigating Lysosomal Storage Diseases in Minority Groups | Huxley